Clinical analysis of 273 adverse drug reaction reports of antineoplastics in our hospital
Haiwei WU,Yu BAI,Hong LIU,Yanhua ZHANG
2017-01-01
Abstract:Objective To analyze the characteristics and general rules of adverse drug reaction (ADR) in Beijing Cancer Hospital of Peking University ("our hospital" for short) in order to provide reference for further developing clinical pharmaceutist guiding rational drug use,and reduce the incidence of ADR.Methods The ADRs reports in our hospital from September 2015 to September 2016 were downloaded from the national ADR monitoring system,and the ADRs of antineoplastic drugs were screened,and the data was taken statistics and analysis by excel software.Results Among 273 cases of ADRs caused by antineoplastic drugs reported from September 2015 to.September 2016,there were 19 cases of ADRs caused by auxiliary antineoplastic drugs.The male to female ratio of ADRs was 0.9∶1,the age group was mainly concentrated in 50-＜60 years old,total 92 cases (33.70％).The main route of administration causing ADRs was intravenous dripping (255 cases,93.41％).The organs or systems involved by ADRs were constitutional reaction (27.97％),skin reaction (16.52％) and cardiovascular system reaction (13.22％).The main clinical symptoms were allergic reactions (51 cases,11.23％),shortness of breath (33 cases,7.27％),fever (28 cases,6.17％),chest distress (27cases,5.59％) and skin rush (26 cases,5.73％).The highest incidence rate of ADR drugs were Oxaliplatin (71 cases,20.70％) and Paclitaxel (57 cases,16.62％).Conclusion Clinical pharmacist should take initiative to monitor ADR of antineoplastics drugs.Combined with detection of pharmacogenomics,clinical pharmacist should formulate individualized treatment plan,so as to promote rational drug use,prevent and reduce the incidence of ADRs.